Vistagen Therapeutics, Inc.
VTGNNasdaqCIK 1411685HealthcareFiscal year ends Mar 31
Reports and events: 388 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3017:24 ET | 8-K | 2.05 Exit or disposal costs; 8.01 Other events | 0001628280-26-068627 |
| 2026-10-0917:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-065559 |
| 2026-09-2509:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-063510 |
| 2026-09-2407:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-063316 |
| 2026-09-2216:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-063046 |
| 2026-09-1119:24 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-061445 |
| 2026-08-1416:12 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-057116 |
| 2026-08-1408:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-056953 |
| 2026-08-0616:16 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-054341 |
| 2026-08-0516:04 ET | 8-K | 3.01 Delisting notice | 0001628280-26-053304 |
| 2026-07-3116:10 ET | DEF 14A | Proxy statementPeriod 2026-07-31 | 0001628280-26-051404 |
| 2026-07-3108:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-051251 |
| 2026-06-3008:28 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-046143 |
| 2026-06-1717:13 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-043989 |
| 2026-06-1516:50 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001628280-26-043271 |
| 2026-06-1516:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-043232 |
| 2026-06-0917:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-041962 |
| 2026-05-1916:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-036492 |
| 2026-05-1207:44 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-033883 |
| 2026-05-0816:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-032935 |
| 2026-04-2816:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-027930 |
| 2026-04-1317:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-024943 |
| 2026-04-0216:16 ET | 8-K | 3.01 Delisting notice | 0001628280-26-023176 |
| 2026-03-1816:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-019455 |
| 2026-03-1616:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-018163 |
| 2026-03-1107:02 ET | 8-K | 8.01 Other events | 0001628280-26-016652 |
| 2026-02-2009:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-010035 |
| 2026-02-1216:38 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001628280-26-007718 |
| 2026-02-1216:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-007715 |
| 2026-02-0616:12 ET | 8-K | 3.01 Delisting notice | 0001628280-26-006078 |
| 2026-01-0917:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001690 |
| 2025-12-2217:29 ET | 8-K | 8.01 Other events | 0001628280-25-058594 |
| 2025-12-0316:47 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-055083 |
| 2025-11-1316:35 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-052079 |
| 2025-11-1316:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-052077 |
| 2025-11-0416:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-048827 |
| 2025-10-2917:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-047188 |
| 2025-09-1516:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001411685-25-000081 |
| 2025-08-0716:57 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001411685-25-000064 |
| 2025-08-0716:56 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001411685-25-000062 |
| 2025-07-2817:14 ET | DEF 14A | Proxy statementPeriod 2025-09-09 | 0001411685-25-000052 |
| 2025-06-2516:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001411685-25-000048 |
| 2025-06-1716:44 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001411685-25-000046 |
| 2025-06-1716:35 ET | 10-K | Annual reportPeriod 2025-03-31 | 0001411685-25-000041 |
| 2025-06-0216:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001411685-25-000028 |
| 2025-03-0616:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001411685-25-000023 |
| 2025-02-1317:25 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001411685-25-000019 |
| 2025-02-1316:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001411685-25-000017 |
| 2025-02-0517:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001411685-25-000011 |
| 2025-01-1417:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001411685-25-000007 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:32 ET. Listed shows no prices and gives no investment advice.